This article is a correction to:
Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer
Yangyang Guo1,2†
Qiaoqiao Chen3,4†
Yingjue Zhang5†Xu Cheng6†
Kenan Cen7Ying Dai7Yifeng Mai7*
Kai Hong1,2*- 1Department of Thyroid and Breast Surgery, Ningbo First Hospital, Ningbo, China
- 2Department of Thyroid and Breast Surgery, Ningbo Hospital of Zhejiang University, Ningbo, China
- 3Reproductive Medicine Center, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
- 4Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
- 5Department of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, Osaka University, Suita, Japan
- 6Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China
- 7The Affiliated Hospital of Medical School of Ningbo University, Ningbo, China
A Corrigendum on
Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer
by Hong K, Chen Q, Zhang Y, Cheng X, Cen K, Dai Y, Mai Y and Guo Y (2023). Front. Genet. 13:1038207. doi: 10.3389/fgene.2022.1038207
In the published article, there was an error in the Author list. The error Author list is “Kai Hong 1,2†, Qiaoqiao Chen 3,4†, Yingjue Zhang 5†, Xu Cheng 6†, Kenan Cen 7, Ying Dai7, Yifeng Mai7* and Yangyang Guo1,2*.” The corrected author list appears below.
“Yangyang Guo 1,2†, Qiaoqiao Chen 3,4†, Yingjue Zhang 5†, Xu Cheng 6†, Kenan Cen 7, Ying Dai7, Yifeng Mai7* and Kai Hong1,2*.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: breast cancer, ubiquitination, immunotherapy, LASSO, signature, tumor microenvironment
Citation: Guo Y, Chen Q, Zhang Y, Cheng X, Cen K, Dai Y, Mai Y and Hong K (2023) Corrigendum: Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer. Front. Genet. 14:1217912. doi: 10.3389/fgene.2023.1217912
Received: 06 May 2023; Accepted: 15 May 2023;
Published: 23 May 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Guo, Chen, Zhang, Cheng, Cen, Dai, Mai and Hong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yifeng Mai, fymaiyifeng@nbu.edu.cn; Kai Hong, hongkai0629@163.com
†These authors have contributed equally to this work